4.6 Article

Estimating the Use of Potentially Inappropriate Medications Among Older Adults in the United States

Journal

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
Volume 68, Issue 12, Pages 2927-2930

Publisher

WILEY
DOI: 10.1111/jgs.16779

Keywords

potentially inappropriate prescribing; older adults; Medicare Part D

Funding

  1. Sinai Department of Medicine Research Fund
  2. Carney Family Foundation

Ask authors/readers for more resources

OBJECTIVES Inappropriate prescribing of medications is common in health care, and is an important safety concern, especially for older adults, who have a high burden of comorbidity and are at greater risk for medication-related adverse events. This study aims to estimate the extent and cost of potentially inappropriate prescribing of medications to older adults in the United States. DESIGN A cross-sectional study. SETTING Medicare Part D Prescription Drug Program data set (2014-2018). PARTICIPANTS Older adults who were enrolled in Medicare Part D Prescription Drug Program between 2014 and 2018. MEASUREMENTS Potentially inappropriate medications were identified using the 2019 American Geriatrics Society Beers Criteria (R). RESULTS In 2018, 7.3 billion doses of potentially inappropriate medications were dispensed. The most common medications by number of doses dispensed were proton pump inhibitors, benzodiazepines, and tricyclic antidepressants, and the top five unique medications by reported spending were dexlansoprazole, esomeprazole, omeprazole, dronedarone, and conjugated estrogens. From 2014 to 2018, 43 billion doses of potentially inappropriate medications were dispensed, with a reported spending of $25.2 billion. CONCLUSION Potentially inappropriate medication use among older adults is both common and costly. Careful attention to potentially inappropriate medication use and deprescribing when clinically appropriate could reduce costs and potentially improve outcomes among older adults.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available